Oncosil Medical Ltd has released a press release.
Oncosil submits Clinical Study Report to Notified Body
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from OncoSil Medical
- Clinical Programme Update
- Oncosil Medical Share Purchase Plan
- Successful Completion of Capital Raising
- Presentation-Surgical Resection Outcomes and Capital Raising
- Positive Early Study Results Continue
Later from OncoSil Medical
- Response to Price Query
- Appendix 4C & Quarterly Update
- Preliminary Final Report
- IQVIA appointed EU Market Access and Reimbursement Advisor
- R&D Refund - 2018 Financial Year
Follow OncoSil Medical into a list and get an email when it puts out news.
Follow OncoSil Medical